APA (7th ed.) Citation

Mamand, S., Allchin, R. L., Ahearne, M. J., & Wagner, S. D. (2018). Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. Scientific Reports, 8(1), 1. https://doi.org/10.1038/s41598-018-32634-5

Chicago Style (17th ed.) Citation

Mamand, Sami, Rebecca L. Allchin, Matthew J. Ahearne, and Simon D. Wagner. "Comparison of Interleukin-2-inducible Kinase (ITK) Inhibitors and Potential for Combination Therapies for T-cell Lymphoma." Scientific Reports 8, no. 1 (2018): 1. https://doi.org/10.1038/s41598-018-32634-5.

MLA (9th ed.) Citation

Mamand, Sami, et al. "Comparison of Interleukin-2-inducible Kinase (ITK) Inhibitors and Potential for Combination Therapies for T-cell Lymphoma." Scientific Reports, vol. 8, no. 1, 2018, p. 1, https://doi.org/10.1038/s41598-018-32634-5.